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Cannabinoid type 1 receptor mediates depot-specific
effects on differentiation, inflammation and
oxidative metabolism in inguinal and epididymal
white adipocytes
IV Wagner, N Perwitz, M Drenckhan, H Lehnert and J Klein
Department of Internal Medicine I, University of Luebeck, Luebeck, Germany
Objective: The endocannabinoid system is a major component in the control of energy metabolism. Cannabinoid 1 (CB1)-
receptor blockade induces weight loss and reduces the risk to develop the metabolic syndrome with its associated cardiovascular
complications. These effects are mediated by central and peripheral pathways. Interestingly, weight loss is mainly achieved by
a reduction of visceral fat mass. We analyzed fat depot-specific differences on adipocyte differentiation, inflammation and
oxidative metabolism in CB1-receptor knockout cells.
Materials and methods: We used newly generated epididymal/inguinal adipose cell lines from CB1-receptor knockout mice.
Differences in differentiation were measured by fat-specific Oil Red O staining and quantitative analysis of key differentiation
markers. Induction of apoptosis was evaluated by cell death detection and investigation of p53 phosphorylation. Inflammation
markers were quantified by real-time PCR. For analyzing the process of transdifferentiation we measured oxygen consumption
and mitochondrial biogenesis.
Results: Differentiation was reduced in visceral adipocytes from CB1-receptor knockout mice as compared with wild-type
controls. Moreover, we found an induction of apoptosis in these cells. In contrast, subcutaneous adipocytes from CB1-receptor
knockout mice showed an accelerated differentiation and a reduced rate of apoptosis. Inflammation was increased in visceral fat
cells, as analyzed by the expression pattern of interleukin-6, monocyte chemoattractant protein 1 (MCP-1), tumor necrosis
factor-a, whereas in subcutaneous adipocytes these markers were decreased. Furthermore, subcutaneous CB1-receptor
knockout cells were more sensitive toward a conversion into a brown fat phenotype. Uncoupling protein-1 as well as PGC-1a
expression was significantly elevated. This was accompanied by an increase in mitochondrial biogenesis and oxygen
consumption.
Conclusion: In conclusion, we found depot-specific effects on differentiation, apoptosis, inflammation and oxidative
metabolism in CB1-receptor knockout cells. Thus, CB1-receptor-mediated pathways differentially target adipose tissue depots
to a dual effect that minimizes cardiometabolic risk, on the one hand, by diminishing visceral fat, and that enhances
thermogenesis in subcutaneous adipocytes, on the other.
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Introduction
Obesity and related cardiovascular complications are one of
the major health problems at present. Obesity is commonly
seen as a disorder of energy balance, where energy
intake exceeds energy expenditure.
1,2 Alteration of adipocyte
function is a critical component in the pathogenesis of
obesity and its related cardiometabolic complications.
3
The endocannabinoid (EC) system is emerging as a key
player in the control of energy homeostasis.
4 It stimulates a
positive energy balance via both central and peripheral
pathways. The cannabinoid 1 (CB1) receptor is distributed in
brain areas and is associated with motor control, emotional
responses, motivational behavior and energy homeostasis. In
the periphery, the same receptor is expressed in adipose Received 2 March 2011; revised 14 June 2011; accepted 10 July 2011
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the heart and in the reproduction system. Stimulation of the
CB1-receptor with a specific agonist WIN 55212.2 has a
negative impact on thermogenesis in brown adipocytes and
favors a positive energy balance by regulating glucostatic
adipokines.
5 In contrast, CB1-receptor-deficient mice have
less fat mass than their wild-type littermates and are protected
against diet-induced obesity.
6 Blocking the receptor with a
selective CB1-receptor antagonist rimonabant induces weight
loss, increases insulin sensitivity, and improves cardiovascular
risk factors in overweight patients.
7 The mechanisms respon-
sible for these effects remain only partially elucidated.
Recently, Tedesco et al.
8 and our group presented several lines
of evidence, that a direct blockade of peripheral CB1-receptor
action in adipose tissue induces transdifferentiation in white
adipocytes toward a thermogenic active brown fat cell
phenotype and enhances insulin sensitivity.
3
Different depots of white adipose tissue appear to exert
different endocrine functions.
9–11 Excess of visceral abdominal
fat is known to be metabolically harmful and is associated with
high levels of cholesterols, hyperlipidemia, insulin resistance
and a high risk to develop atherosclerotic cardiovascular
disease.
9–11 By contrast, subcutaneous fat may behave differ-
ently and even have a protective role.
12–15 Porter et al.
10
concluded after having analyzed more than 3001 patients
(Framingham heart study) that although adiposity increases
the absolute risk of metabolic and cardiovascular disease,
abdominal subcutaneous fat is not associated with a linear
increase in the prevalence of factors that are related to obesity.
Indeed, in the case of high triglycerides, subcutaneous adipose
tissue may actually be a protective fat depot in obese
humans.
10,13 Visceral adipose tissue and subcutaneous adipose
tissue differ not only in their anatomic location and metabolic
function but also in their cytokine secretion profile. Sub-
cutaneous adipose tissue releases two to three times more
leptin than visceral adipose tissue;
16 whereas visceral adipose
tissue secretes more adiponectin, interleukin (IL)-6 and -8,
plasminogen activator–inhibitor 1, and angiotensin than does
subcutaneous adipose tissue.
17
Finally brown adipose tissue has a role in adaptive
thermogenesis, the part of energy expenditure induced by
cold exposure or diet.
18–21 Brown adipose tissue dissipates
energy by uncoupling oxidative phosphorylation from ATP
production. This process is mediated by uncoupling protein-1
(UCP-1). UCP-1 expression, in turn, is critically regulated
by the transcriptional coactivator PGC-1a, which increases
the transcriptional activity of peroxisome proliferator-
activated receptor g (PPARg) on the UCP-1 promoter.
22
Ectopic expression of PGC-1a in white adipose cells activates
expression of UCP-1, key mitochondrial enzymes of the
respiratory chain, and also enhances the cellular mitochon-
drial DNA.
23 PGC-1a is expressed at higher levels in brown
adipose tissue than in white adipose tissue, and its expres-
sion is increased in response to cold exposure and
b-adrenergic stimulation. PPARg and its coactivators,
PGC-1a and SRC-1, influence brown adipocyte metabolism
and development. Tiraby and Langin
1 showed evidence to
support the concept of an alteration in energy balance
through a conversion of white to brown adipose tissue.
Emergence of brown fat cells in white fat depots is associated
with a lean phenotype in transgenic mouse models.
24,25
Transgenic expression of PRDM 16, at physiological levels, in
white fat depots stimulates the formation of brown fat
cells.
26 It seems therefore possible that therapeutic strategies
aiming at altering the phenotype of white adipocytes could
be developed or used for the treatment of obesity.
The peripheral mechanisms responsible for a reduction
of visceral adipose tissue and the induction of a negative
energy balance when blocking the CB1-receptor remain
only partially elucidated. Here, we demonstrate depot-
specific effects in differentiation, apoptosis, inflammation
and oxidative metabolism in subcutaneous compared with
visceral adipocytes of CB1-receptor knockout mice.
Materials and methods
Materials
Antibody against PGC-1a, phospho-p53 (Ser15), p53 and
Pref-1 were ordered from Cell Signaling Technology Inc.
(Beverly, MA, USA). The UCP-1, cannabinoid type 1 receptor
and actin antibodies were purchased from Chemicon
International (Temecula, CA, USA). The antibodies used
against AP2 and PPARg were from Santa Cruz Biotechnology
Inc. (Santa Cruz, CA, USA). Primers for quantitative real-time
PCR were ordered from Biometra (Goettingen, Germany).
Glucose uptake assays were performed with 2-deoxy-3H
glucose from NEN Life Technologies (Deirich, Germany).
All other chemicals were from Sigma-Aldrich Co. (St Louis,
MO, USA), unless stated otherwise.
Methods
Generation of adipose cell lines. Periepididymal and inguinal
adipose tissues were taken from CB1-receptor knockout and
wild-type mice.
Adipose tissue was taken from periepididymal and
inguinal regions. After collagenase digestion (1mg colla-
genase in 1ml isolation buffer containing 0.123mM NaCl,
5m M KCl, 1.3mM CaCl2,5 m M glucose, 100mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid, 100Uml
1
penicillin/streptomycin and 4% bovine serum albumin),
cells were transferred to culture plates and grown to 60–70%
confluence. Cells were immortalized with SV40T antigen.
Selection began after 72h with puromycin (2mgml
1)a n dw a s
maintained for 3 weeks. The study was conducted according
to the NIH guidelines for the care and use of laboratory
animals, and was authorized by the local regulatory authority
(Ministerium fuer Landwirtschaft, Umwelt und laendliche
Raeume des Bundeslandes Schleswig-Holstein).
Cell culture
Immortalized wild-type cells as well as newly generated
CB1-receptor knockout cell lines from epididymal and
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Eagle’s medium supplemented with 20% fetal bovine serum,
4.5gl
1 glucose, 20nM insulin and 1nM triiodthyronine
(differentiation medium) in a humified atmosphere of 5%
CO2 at 371C. When preadipocytes reached confluence, cell
differentiation was induced by 250mM indomethacine,
500mM isobutylmethhylxanthine and 2mgml
1 dexametha-
sone for 24h (induction medium). Subsequently, cells were
grown in differentiation medium for another 6 days,
depending on the experiments performed.
27,28
Western blot analysis/immunoblotting
After washing the cells with ice-cold phosphate-buffered
saline, proteins were isolated using cell lysis buffer contain-
ing 2mM vanadate, 10mgml
1 aprotinin, 10mgml
1 leupep-
tin and 2mM phenylmethylsulphonylfluoride. The protein
content was quantified using the Bradford protein assay
according to the manufacturer’s instructions (Bio-Rad,
Munich, Germany). Proteins were separated by SDS-poly-
acrylamide gel electrophoresis and transferred to nitro-
cellulose membranes (Schleicher and Schuell, Dassel,
Germany). Membranes were blocked with rinsing buffer
(10mM Tris, 150mM NaCl and 0,05% Tween, pH 7.2) inclu-
ding 3% bovine serum albumin or 5% skim milk at 41Co v e r -
night. Protein bands were visualized using chemiluminescence
(Perkin-Elmer GMbH, Rodgau-Ju ¨gesheim, Germany) and
enhanced chemiluminescence films (Amersham Pharmacia
Biotech, Freiburg, Germany). The subsequent quantification
was performed using Quantity One Software (Bio-Rad). Gel
loading was normalized using actin as a control protein.
RNA isolation and quantitative real-time PCR
Total RNA was isolated using QIAzol reagent (Qiagen,
Hilden, Germany). To optimize the RNA quality a clean
up and DNase digestion were performed using the NucleoS-
pin RNA II Kit (Macherey-Nagel, Dueren, Germany). Quality
of RNA was tested by photometric analysis and agarose gel
electrophoresis. An amount of 2mg total RNA was reverse
transcribed using Superscript II (Invitrogen, Karlsruhe,
Germany) and an oligo p(DT)15 primer (Roche Molecular
Biochemicals, Mannheim, Germany) in the presence
of RNase inhibitor (Roche Molecular Biochemicals). Quanti-
tative real-time PCR were performed using 1 SYBR
Premix Ex Taq (TaKaRa Bio Europe, Saint-Germaine-Laye,
France) in a Mastercycler ep realplex (Eppendorf GmbH,
Hamburg, Germany). PCR for all targets was performed as
follows: initial denaturation at 951C for 300s, 40 cycles with
951C for 20s, 601C for 30s. Specific amplification was
confirmed by producing melting curve profiles and by
subjecting the amplification products to agarose gel electro-
phoresis. 36B4 served as a housekeeping gene. Relative
quantification was done by using the Mastercycler ep
realplex software based on the CT method (DDCt method
software for relative quantification).
29 Primer sequences are
available on request.
Oil Red O staining
Cells were cultivated in 10-cm plates and fat-specific staining
was performed with Oil Red O at days 0, 3 and 6 after
induction. For this purpose, adipocytes were washed twice
with phosphate-buffered saline and cells were subsequently
fixed with 10% formalin for at least 20min. Afterwards, cells
were exposed to Oil Red O for 1h at room temperature
(stocking solution: 0.5g Oil Red O in 100ml isopropanol;
working solution: 60% stocking solution plus 40% H2O). To
remove the staining solution, cells were washed several times
with distilled water. Representative macroscopic as well as
microscopic pictures at a 40-fold magnification were taken
using a digital camera (Olympus E330, Olympus Imaging
Europe, Hamburg, Germany). For densitometric analysis, Oil
Red O stain was removed by incubating the cells with
isopropanolol for 15min. Optical density was measured at a
wavelength of 500nm in a photometer.
Glucose uptake
Fully differentiated cells were serum deprived 24h before the
experiment. After washing the cells twice with Krebs–Ringer
buffer, cells were incubated with or without insulin
(1nM,1 0 n M or 100nM) for 30min. Then a mix of 1mM
2-desoxyglucose and 50mCiml
1 2-desoxy-3H glucose was
added for additional 3min. Cells were washed in phosphate-
buffered saline, and lysed with 0.1% SDS. The incorporated
radioactivity was determined by liquid scintillation counting.
Apoptosis
A photometric enzyme immunoassay for the qualitative and
quantitative in vitro determination of cytoplasmic histone-
associated DNA fragments after cell death was performed
using a cell death detection ELISA plus kit (Roche Molecular
Biochemicals, Mannheim, Germany) according to the
manufactures’s instructions.
Oxygen consumption
The respiration rate of preadipocytes and adipocytes was
measured by using a Clark-type oxygen electrode (Oxygraph
System, Hansatech, England). Adipocytes at days 0 and 6 of
differentiation were detached off the plate and trypsinated.
Trypsin was stopped with medium and the suspension was
centrifuged for 3min (1500r.p.m.) rinsed with phosphate-
buffered saline. The pellet was then resuspended in Dulbecco’s
modified Eagle’s medium without supplements. Each sample
was analyzed by incubating at least 10
6 cells over a period of
10min. Measurement was made in a magnetically stirred
chamber, connected to a water circulation system to maintain
as t a b l ec h a m b e rt e m p e r a t u r e( 3 7 1C). The incoming signals
were detected by software from Hansatech and converted into
graphs. The rate of consumption was normalized against the
number of living cells, which were stained with Trypan blue
and were then counted in a Neubauer’s counting chamber.
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Adipocytes at day 6 of differentiation were trypsinated,
washed at least twice with phosphate-buffered saline and
were then fixed in 4% paraformaldehyde for at least
30min. Labelling was done using 100nM MitoFluor Green
(Invitrogen) for 20min at room temperature as described by
the manufacturer. After staining the fluorescence intensity of
the cells was determined by FACS Canto (Becton and
Dickinson Biosciences, San Jose, CA, USA) and analyzed by
the Flow Software (Tree Star, Ashland, OR, USA).
Statistical analyses
Statistical analyses were performed with Sigma Plot software
(SPSS Science, Chicago, IL, USA). Results are presented as mean
values±s.e.m. Statistical significance was determined using the
unpaired Student’s t-test. P-values o0.05 were considered
significant, and those o0.01 were defined as highly significant.
Results
Depot-specific effects of CB1-receptor knockout on adipocyte
differentiation
In epididymal adipocytes of CB1-receptor knockout, we
found a lack of differentiation compared with controls,
whereas inguinal CB1-receptor knockout cells demonstrated
an accelerated lipid storage compared with inguinal wild-
type cells as assessed by microscopic pictures after Oil Red O
staining (Figure 1). These observations were confirmed by
densitometric analysis of Oil Red O staining (Figures 2a
and b). Lipid accumulation in epididymal CB1-receptor
knockout cells was significantly reduced on days 3 and 6.
In contrast, inguinal CB1-receptor knockout cells showed an
increase in differentiation on days 3 and 6. Furthermore, we
analyzed main differentiation markers in these cells at days
3 and 6 after induction. The Preadipocyte factor (Pref 1),
which is an inhibitory factor of adipogenesis, was markedly
induced with a maximum of nearly 700% on day 6 in
epididymal CB1-receptor knockout cells, whereas in inguinal
cells this marker was significantly reduced by 70%. In line
with these results, we found a decrease of PPARg, Glut 4 and
aP2 in epididymal CB1-receptor knockout fat cells by 40%,
68% and 52%, respectively. In inguinal CB1-receptor knock-
out cells, the expression of these late differentiation markers
was elevated (233% PPARg, 467% aP2, 33% Glut 4) compared
with their wild-type controls (Table 1).
CB1-receptor knockout enhances insulin sensitivity in inguinal
adipocytes
Insulin-induced glucose uptake was found to be impaired
in epidiymal CB1-receptor knockout cells by 10% (1nM),
Epi CB1R KO
Epi Wildtype
Ing CB1R KO
Ing Wildtype
Day 0 Day 3 Day 6
Figure 1 Depot-specific effects on adipocyte differentiation are demonstrated. Oil Red O staining of newly generated inguinal (Ing) and epididymal (Epi) CB1-
receptor knockout (KO) cells compared with their wild-type control. Lipid accumulation was visualized at days 0, 3 and 6 during adipogenesis. Microscopic pictures
in 40-fold magnification are shown.
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CB1-receptor knockout cells showed an enhancement in
g l u c o s eu p t a k ew i t ha ni n c r e a s eo f2 1 %( 1 n M), 35% (10nM),
30% (100nM) compared with their wild-type controls (Figure 3).
CB1-receptor knockout induces apoptosis in epididymal but not
in inguinal cells
We next assessed the phosphorylation of p53, a marker for
apoptosis. We found a highly significant increase of p53
phosphorylation in epididymal knockout cells compared with
their control cells. This effect was dose-dependent with a 562%
increase on day 3 and 1329% on day 6 of the differen-
tiation cycle. In contrast, inguinal CB1-receptor knockout cells
showed a reduction in p53 phosphorylation by 57% on day 3
and 84% on day 6 (Figure 4). To confirm these data, we next
examined apoptotic cell death in both cell depots at day 0. In
line with the results for p53 phosphorylation, we also found
an increase of cell death in epididymal CB1-receptor knock-
outs by B51%, whereas inguinal CB1-receptor knockout cells
resulted in a significantly decreased apoptotic rate by 41%
when compared with their control cells (Figure 5).
CB1-receptor knockout influences inflammatory adipokine gene
expression in a depot-specific matter
To examine the effect of a CB1-receptor blockade on
inflammation, we measured IL-6, monocyte chemoattractant
protein 1 (MCP-1) and tumor necrosis factor (TNF)-a
mRNA expressions in epididymal and inguinal CB1-receptor
knockout preadipocytes (Figure 6). In epididymal
knockout cells all proinflammatory markers were elevated.
We found a 156% increase of IL-6, MCP-1 was induced by
200% and TNF-a by 192% compared with epididymal
control preadipocytes. In contrast, there was a decrease in
inguinal CB1-receptor preadipocytes of IL-6, MCP-1 and
TNF-a by 40%, 5% and 23%, respectively. These findings
were even more pronounced on day 3 of the differentiation
process. An increase in the expression profile of IL-6, MCP-1
and TNF-a by 357%, 326% and 371%, respectively, was
found in epididymal CB1-receptor knockout cells, as well as
a decreased expression of these inflammation markers in
inguinal CB1-receptor knockout cells (IL-6 60%, MCP-1 26%,
TNF-a 32%) when compared with their wild-type controls.
CB1-receptor knockout enhances brown fat cell marker
expression in inguinal cells, whereas reducing it in epididymal
cells
In epididymal cells, the expression of PGC-1a, a transcrip-
tional activator of PPARg on the UCP-1 promoter, was
slightly but not significant reduced by 23% in preadipocytes
(because of high standard deviation results were not
significant), but was significantly decreased by 64% in
mature cells when compared with controls. In contrast,
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Figure 2 (a, b) Densitometric analysis was performed after Oil Red O staining of the adipocytes. Bar graph analyses showed intensity of Oil Red O (optical density)
measured on days 0, 3 and 6. CB1-receptor knockout (KO) cells were compared with their wild-type (WT) controls. Eight independent experiments are shown in a
and b as mean±s.e.m.,*Po0.05, **Po0.01 comparing wild types to CB1-receptor knockout cells. EPI, epididymal; ING, inguinal.
Table 1 Markers of adipocyte differentiation were decreased in epididymal CB1R KO cells, whereas they were enhanced in inguinal CB1R KO adipocytes
Differentiation marker Pref 1 PPARg aP2 Glut 4
Day of differentiation Day 3 Day 6 Day 3 Day 6 Day 3 Day 6 Day 3 Day 6
Epididymal WT vs KO m 121% m 699% k 44% k 39% k 27% k 52% k 35% k 68%
Inguinal WT vs KO k 69% k 65% m 186% m 233% m 132% m 467% m 49% m 33%
Abbreviations: CB1R, cannabinoid 1 receptor; KO, knockout; PPARg, peroxisome proliferator-activated receptor g; Pref 1, preadipocyte factor; WT, wild type. Table 1a
compares epididymal WT cells to epididymal KO cells, whereas in table 1b the contrast of inguinal wild-type cells to inguinal KO cells is demonstrated. Data are shown
for day 3 and day 6. Pref-1 is an inhibitory marker of early adipogenesis, whereas aP2, PPARg and GLUT 4 are favorable markers of late adipogenesis.
The percentage of their respective increase (m) or decrease (k) is demonstrated in the table. All data are normalized using 36B4 as a housekeeping gene. On average
six independent experiments are shown. WT control cells are compared to CB1-receptor knockout cells.
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Nutrition and Diabetesinguinal preadipocytes showed a highly significant increase
of PGC-1a expression by 152% in preadipocytes and a
significant enhancement of 315% in mature cells (Figure 7).
In line with these results, the expression of UCP-1 did not
differ significantly in epididymal preadipocytes, whereas the
mature cells showed a significantly decreased expression by
57% of this brown fat cell marker. There was an increased
basal expression of UCP-1 in inguinal CB1-receptor knockout
cells by 252% at day 0 and 243% at day 6 compared with
inguinal control cells (Figure 8).
CB1-receptor knockout promotes mitochondrial biogenesis
in inguinal white adipocytes
In consequence of our findings of an increased PGC-1a
and UCP-1 content in inguinal CB1-receptor knockout
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Figure 3 (a, b) CB1-receptor knockout (KO) influences insulin sensitivity in a depot-specific manner. Glucose uptake was measured using 2-desoxy-3H glucose.
Mature fat cells were stimulated with different insulin concentrations (1nM,1 0n M and 100nM insulin per well) for 30min. The black line shows the wild-type (WT)
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shown as mean±s.e.m., *Po0.05, **Po0.01 comparing wild types to CB1-receptor KO cells.
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Figure 4 (a, b) CB1-receptor knockout (KO) enhances p53 phosphorylation in epididymal (EPI) cells while reducing it in inguinal (ING) adipocytes. (a) The
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Nutrition and Diabetesadipocytes, we investigated the expression of mitochondrial
markers during adipogenesis in these cells compared with
epididymal CB1-receptor knockout cells. Although there
were no changes in Tfam and NRF-1 expression in pre-
adipocytes, we found an increase of both markers in inguinal
adipocytes on days 3 and 6 of the differentiation process.
In epididymal cells, the expression of these markers was
unaltered (data not shown). To confirm an induction of
mitochondrial biogenesis, we further used a mitochondrial-
specific fluorescent staining. We found a significant decrease
of fluorescent intensity in epididymal cells by 20%. In
contrast, the fluorescent intensity in inguinal cells was
increased by 52% (Figure 9).
Oxygen consumption is increased in inguinal CB1-receptor
knockout cells
We finally examined the rate of oxygen consumption as a
cellular read-out for increased respiratory chain activity.
Epididymal CB1-receptor knockout cells displayed a reduced
rate of oxygen consumption by 30% at day 0 and 27% at
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Figure 5 Apoptosis is induced in epidiymal (EPI) CB1-receptor knockout
(KO) cells. A photometric enzyme immunoassay for the determination of
cytoplasmic histone-associated DNA fragments after cell death was per-
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Figure 6 (a, b) Expression of inflammation markers was elevated in epididymal (EPI) knockout (KO) cells and decreased in inguinal (ING) KO cells, which was
quantified using real-time PCR. Data of inflammation markers including IL-6, monocyte chemoattractant protein 1 (MCP-1) and TNF-a are shown in a at day 0 and b
at day 3. The dark gray bars show the increase of expression levels of EPI KO cells in % and the light gray bars demonstrate the reduction of inflammation markers in
ING KO cells in % compared with their individual wild-type controls (set as 100%). All data were normalized using 36B4 as a housekeeping gene. Of each
inflammation marker six independent experiments are shown as mean±s.e.m., *Po0.05, **Po0.01 comparing wild-type control cells to CB1-receptor KO cells.
Inguinal White Adipocytes Epididymal White Adipocytes
600 250
400
500
150
200
**
*
300
100
**
P
G
C
-
1
 
a
l
p
h
a
 
E
x
p
r
e
s
s
i
o
n
(
%
 
o
f
 
W
T
)
100
200
P
G
C
 
-
1
 
a
l
p
h
a
 
E
x
p
r
e
s
s
i
o
n
(
%
 
o
f
 
W
T
)
50
0
DAY 0
0
KO EPI KO EPI WT EPI WT EPI
DAY 6 DAY 0
KO ING KO ING WT ING WT ING
DAY 6
Figure 7 (a, b) PGC-1a expression is increased in inguinal (ING) knockout (KO) cells. Expression is illustrated at days 0 and 6 during the differentiation process.
(a) Compares PGC-1a expression of epididymal wild-type (WT) cells and epididymal (EPI) CB1-receptor KO cells, (b) shows PGC-1a expression of ING WT cells
compared with ING CB1-receptor KO cells. All data normalized using 36B4 as a housekeeping gene. Six independent experiments are shown as mean±s.e.m.,
*Po0.05, **Po0.01 comparing WT control cells to CB1-receptor KO cells.
Depot-specific effects after CB1-receptor blockage
IV Wagner et al
7
Nutrition and Diabetesday 6 compared with wild-type controls. In contrast, oxygen
consumption in inguinal CB1-receptor knockout adipocytes
was found to be significantly elevated by 83% at day 0 and by
92% at day 6 compared with wild-type controls (Figure 10).
Discussion
To distinguish between different fat depot functions has
become the focus of intensive research recently. Visceral
fat distribution in obesity is strongly linked to metabolic
complications of obesity because of a greater infiltration
of adipose tissue with inflammatory cells, excess release of
potentially harmful cytokines and reduced release of bene-
ficial adipokines.
11,30 In contrast, abdominal subcutaneous
fat is not associated with a linear increase in the prevalence
for metabolic and cardiovascular diseases. Our results show,
for the first time, a depot-specific effect of a CB1-receptor
knockout in adipocytes. Interestingly, CB1-receptor knock-
out cells promote a metabolically beneficial status for
subcutaneous fat cells, such as increased insulin sensitivity,
decreased inflammation and an enhancement in mitochon-
drial biogenesis combined with an induction of oxygen
consumption when compared with epididymal wild-type
cells. The EC system has a major role in controlling energy
homeostasis via central and peripheral pathways. Clinical
trials showed that blocking of the CB1-receptor, with the
selective antagonist rimonabant, leads to an induction of
weight loss and improves cardiovascular risk factors in obese
patients.
7,31–33 CB1-receptor knockout mice are protected
against diet-induced obesity.
6,34 Cell proliferation and lipid
accumulation are the major factors contributing to fat mass
development in obesity. Our study demonstrates a depot-
specific effect on adipocyte differentiation. In newly gene-
rated CB1-receptor knockout cell lines from different fat cell
depots, we found an impaired differentiation together with a
decreased expression pattern of differentiation markers in
epididymal cells compared with their wild-type control cells.
Inguinal cells, on the other hand, showed an accelerated
accumulation of lipids accompanied with an increase of
differentiation markers. Effects of ECs on adipogenesis were
investigated in 3T3-L1 adipocytes. Blocking the CB1-receptor
arrested adipocyte proliferation.
35 Furthermore, increased
EC levels promote preadipocyte differentiation and chronic
stimulation of the CB1-receptor during adipogenesis induces
the accumulation of lipids and the elevation of PPARa ˜ as a
differentiation marker.
36,37 These results are in line with our
findings for epididymal fat cells with a lack of differentiation
after CB1-receptor blockage. Thus, blocking the CB1-recep-
tor in adipocytes has an important impact on fat composi-
tion by lipid deposition in inguinal fat on the one hand
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Nutrition and Diabeteswhile reducing epididymal fat mass on the other. Higher
amounts of lower subcutaneous body fat in humans seem to
be associated with a reduced risk of metabolic complica-
tions.
38 Similar observations are shown for selective PPARg
agonists. Thiazolidinediones may induce differentiation of
human preadipocytes isolated from subcutaneous fat but not
those from visceral fat.
39,40 Treatment with PPARg agonists
in rats also redistributes fat by stimulating the lipid uptake
and esterification potential in subcutaneous fat and by
augmentation of oxygen consumption. Conversely, lipid
uptake is minimally altered and energy expenditure is greatly
increased in visceral fat, with consequent reduction in fat
accumulation.
41
Recent studies describe a depot-specific effect on inguinal
and epididymal differentiation in cells treated with dehydro-
epiandrosterone. Again, inguinal preadipocyte differen-
tiation was unaffected or increased, whereas omental
preadipocytes showed significantly reduced adipogenesis.
42
Reduced adipogenesis might be explained by the induc-
tion of apoptosis. Hallenborg et al.
43 showed that p53
inhibits adipogenesis and maintains adipose tissue function.
We demonstrate a significant increase in p53 phosphrylation
in mature epididymal cells compared with their wild-type
controls. In contrast, p53 phosphorylation in inguinal
adipocytes was impaired. These data are in line with other
findings, showing that omental preadipocytes are more
susceptible to apoptotic stimuli than subcutaneous preadi-
pocytes.
44 There are also a lot of other stimuli that have
shown to influence the differentiation process and apop-
totic rate in adipose tissue. For example, after Ajoene (a garlic
extract), Guggulsterone, Withaferin A, Chlorella methanol
and Resveratrol (ingredient of red wine) stimulation or
treatment, a reduced lipid accumulation and adipogenesis
and an increase in the number of apoptotic cells was
noted.
45–48 Altering fat mass by directly affecting cell
viability, adipogenesis and apoptosis, may have applications
for the treatment of obesity and might be one mechanism
for the beneficial effect of blocking the CB1-receptor
with rimonabant. In clinical trials with rimonabant, patients
mainly loose visceral fat, which is evidenced by a reduced
waist to hip circumference. Redistributing fat from
lipolytic visceral fat to more anabolic subcutaneous fat is
thought to have a role in the insulin-sensitizing effect of
PPARg agonists in humans.
41 These results are consistent
with our data showing an elevated glucose uptake in
inguinal CB1-receptor knockout adipocytes and again
underline the insulin-sensitizing effect of rimonabant in
obese patients.
Obesity is associated with chronic inflammation. During
the development of obesity macrophages infiltrate adipose
tissue. This seems to be more pronounced in visceral adipose
tissue rather than in subcutaneous fat.
49 In extremely obese
patients, the visceral fat is the main contributor to high
plasma IL-6 concentrations.
50 Moreover, MCP-1 and TNF-a
are related to adipocyte dedifferentiation and systematic
insulin resistance.
51,52 As compared with subcutaneous
adipose tissue, visceral adipose tissue endocrine activity is
considered to be predominant in contributing to chronic
low-grade inflammation found in obese subjects. This is in
line with our findings demonstrating that CB1-receptor
knockout cells mediate a proinflammatory status by enhan-
cing IL-6, MCP-1 and TNF-a expression in epididymal
cells, whereas reducing these inflammation markers in
inguinal cells.
The conversion of white adipocytes into a thermogenic
active brown fat phenotype is a promising strategy to control
energy homeostasis. We and others have recently published
direct effects of CB1-receptor blockade on thermogenesis,
mitochondrial biogenesis and oxidative metabolism.
A pharmaceutical blockade of the receptor with rimonabant
results in a transdifferentiation of white cells into a brown fat
cell phenotype.
3,8 Both studies did not distinguish between
white fat depots. Only Jourdan et al.
53 examined the impact
of CB1-receptor antagonism on liver and adipose tissue
metabolism in a mouse model of diet-induced obesity.
His research group demonstrated that in visceral but not
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Nutrition and Diabetessubcutaneous fat, genes that are involved in transport,
synthesis, oxidation, and release of fatty acidy were upregu-
lated by HSHF feeding, whereas this effect was counteracted
by CB1-receptor antagonism.
53 They evaluated the deter-
mining factor for the reversion in liver steatosis that can be
induced by rimonabant (SR141716) and found, in line with
our data, that the blockage of the EC system can have
different effects on visceral and subcutaneous fat. TNF-a
expression was reduced in subcutaneous adipose tissue after
treatment with a CB1-receptor antagonist but inflammation
remained high in visceral adipose tissue, as confirmed in
our experiments. Furthermore, Jourdan et al.
53 showed an
increased expression of PPARg in subcutaneous adipose
tissue after CB1-receptor blockage. In addition, we were able
to demonstrate that there is not only a differentiation
benefit in the subcutaneous depot but also furthermore a
lack of differentiation in the metabolically harmful visceral
depot. Furthermore, we observed, in inguinal CB1-receptor
knockout cells, a depot-specific effect of transdifferentiation
in white adipocytes. UCP-1 as well as PGC-1a expressions
were significantly increased in inguinal CB1-receptor knock-
out cells, whereas they were downregulated or not affected
in epididymal cells. Moreover, mitochondrial biogenesis in
inguinal CB1-receptor knockout cells were elevated together
with an increase in oxygen consumption as a final cellular
read-out for increased activity of the respiratory chain. In
contrast, epididymal CB1-receptor knockout cells showed
impairment in both, mitochondrial biogenesis and oxidative
metabolism. Thus, inguinal cells appear to be more sensitive
toward transdifferentiation. The higher expression levels of
markers for brown adipocytes and an increased mitochon-
drial biogenesis in cells that were isolated from subcutaneous
tissues of CB1-receptor knockout mice might partly be due to
the differentiation benefit we noted in these cells compared
with their wild-type controls. In addition, there is likely to
exist another process that induces the transdifferentiation as
we already noted differences at day 0 during the differentia-
tion process independent of lipid accumulation. Relevant
signaling mechanisms currently remain unclear. Interest-
ingly, new studies show that PRDM 16, a key factor for brown
fat cell development, is five- to six-fold higher expressed
in inguinal cells than in epididymal adipocytes, suggesting
that these cells have more potential to convert into brown
fat cells. Previous studies have demonstrated that UCP-1
expression in white adipocytes is increased after chronic
b-adrenergic stimulation or stimulation with a PPARg
agonist. Again this phenomenon is particularly evident in
inguinal depots and less in epididymal adipocytes.
54,55 More-
over, rosiglitazone promotes mitochondrial biogenesis
in vivo in white fat of ob/ob mice as well as in human
subcutaneous fat.
56 However, emergence of brown fat cells
in white fat depots is associated with a lean phenotype in
transgenic mouse models (FOXC2, 4E-BP1).
24,25 These mice
have an enhanced metabolic rate and insulin sensitivity and
are protected against diet-induced obesity. Furthermore,
transgenic mice expressing UCP-1 in white adipose tissue
are protected against genetic and dietary obesity and show
an increase in white adipose tissue oxygen consumption.
57
Developing strategies to enhance brown fat cell cluster in
white adipose tissue depots by converting white adipocytes
might be a tool to treat obesity and associated disorders.
In summary, the present study reveals a depot-specific
effect of cannabinoid action in adipose cells from different
fat depots. In newly generated CB1-receptor knock-
out adipose cell lines, this study demonstrates a deficit in
differentiation and an increase in apoptosis in epididymal fat
cells accompanied by increased inflammation and reduced
oxygen consumption. In contrast, inguinal CB1-receptor
knockout cells show less inflammation and tend to be more
sensitive toward a conversion into a thermogenic active
brown fat phenotype. These findings elucidate peripheral
mechanisms resulting in beneficial effects on energy balance
achieved by blockade of the EC system. Enhanced thermo-
genesis represents a peripheral mechanism contributing to
weight loss and improving glucose homeostasis in patients
treated with a CB1-receptor antagonist. In addition, CB1-
receptor blockade promotes the development of subcuta-
neous fat and reduces visceral fat, which is associated
with metabolic complications of obesity. To use this new
understanding of CB1-receptor blockade for the benefit in
obesity treatment the development of adipocyte-specific
CB1-receptor antagonists should be intensified.
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